비교리스트

 카트 문의
시장보고서
상품코드
1528032

세계의 DNA 시퀀싱 시장

DNA Sequencing
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 392 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

DNA 시퀀싱 시장은 2030년까지 171억 달러에 달할 전망입니다.

2023년에 78억 달러로 추정된 DNA 시퀀싱 시장은 2030년에는 171억 달러에 이를 전망이고 예측 기간 동안 복합 연간 성장률(CAGR)은 11.8%로 성장할 것으로 예측됩니다. DNA 시퀀싱 소모품은 본 보고서에서 분석한 부문 중 하나이며 복합 연간 성장률(CAGR) 11.5%로 성장을 지속하여 분석 기간 종료 시 75억 달러에 달할 것으로 예측됩니다. DNA 시퀀싱 장비 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 10.2%로 추정됩니다.

미국 시장은 31억 달러로 추정, 중국은 복합 연간 성장률(CAGR) 15.9%로 성장할 것으로 예측됩니다.

미국 DNA 시퀀싱 시장은 2023년 31억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 25억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR)은 15.9%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 8.8%와 9.5%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 약 9.0%로 성장할 것으로 예측됩니다.

세계 DNA 시퀀싱 시장 - 주요 동향 및 촉진요인 요약

DNA 시퀀싱란 무엇인가, 왜 변혁을 가져오는 것인가?

DNA 서열은 DNA 분자 내의 뉴클레오티드의 정확한 순서를 결정하는 과정입니다. DNA 사슬에서 4개의 염기(아데닌, 구아닌, 시토신, 티민)의 순서를 결정하는 데 사용되는 모든 방법과 기술이 포함됩니다. DNA의 염기서열을 신속하고 저렴하게 결정하는 능력은 생물학 연구에서 매우 중요한 요소이며, 과학자들은 생물과 바이러스의 발생, 기능, 번식을 유도하는 유전자의 청사진을 관찰 할 수 있습니다. 수 있습니다. 지난 수십년동안, DNA 시퀀싱 기술의 진보는 유전체학 분야에 혁명을 일으켰고, 많은 질병의 유전적 기반, 종의 진화, 집단 간의 유전적 변이의 확인에 대한 깊은 인사이트로 이어졌습니다.

DNA 시퀀싱의 기술은 어떻게 진보했는가?

DNA 시퀀싱의 기술 발전은 Sanger 시퀀싱과 같은 방법을 포함한 1 세대 시퀀싱에서 수백만 개의 작은 DNA 단편의 시퀀싱를 병렬로 수행하여 DNA 시퀀싱과 관련된 시간과 비용을 크게 줄일 수 있습니다. 차세대 시퀀싱(NGS)에 대한 궤적을 거의 따라 왔습니다. NGS 플랫폼은 정확성, 속도 및 가격을 향상시키고 전체 유전체 시퀀싱 및 개별화 유전체학와 같은 대규모 프로젝트를 더 많은 연구자 및 임상의에게 실현할 수 있도록 하는 급속한 향상을 이루었습니다. 네. 또한, 1분자 실시간 시퀀싱 기술을 포함한 3세대 시퀀싱 기술의 개발은 DNA 샘플의 증폭을 필요로 하지 않고, 보다 빠르고 정확한 시퀀싱 기능을 제공함으로써 이 분야에 더욱 혁명을 가져올 것을 약속합니다. 하고 있습니다.

DNA 시퀀싱의 주요 용도는?

DNA 시퀀싱의 응용은 다양하며 다양한 분야에 적용됩니다. 헬스케어는 유전성 질환의 진단, 암으로 이어질 수 있는 돌연변이의 식별, 개인의 유전적 체질에 근거한 치료 방침의 결정에 사용되고 있습니다. 농업 분야에서 DNA 시퀀싱은 식물의 유전자 구조를 정확하게 변화시킴으로써 고수율로 해충에 강한 작물을 만드는 데 도움이 됩니다. 또한, 법의학에서는 시퀀싱을 통해 DNA의 미세 샘플에서 높은 정확도로 개인을 확인할 수 있습니다. 환경 과학자들은 DNA 시퀀싱을 사용하여 생물 다양성을 연구하고, 집단 유전학을 이해하고, 환경 변화가 생태계의 유전 물질에 미치는 영향을 추적합니다. 각 애플리케이션은 복잡한 생물학적 시스템의 이해와 관리를 진행하는 데 DNA 시퀀싱 기술이 큰 영향을 미칩니다는 것을 보여줍니다.

DNA 시퀀싱 시장의 성장은 여러 요인에 의해 초래된다

DNA 시퀀싱 시장의 성장은 급속한 기술 진보, 비용 절감, 다양한 분야로의 응용 확대 등 여러 요인에 의해 견인되고 있습니다. 개별 치료 계획을 조정하기 위해 유전자 정보에 크게 의존하는 정밀의료의 채택이 증가하고 있는 것은 주요 성장 촉진요인입니다. 게다가 정부와 민간 자금 지원을 통한 세계적인 유전자 연구 활동의 활성화는 첨단 시퀀싱 솔루션 수요에 크게 기여하고 있습니다. DNA 시퀀싱를 이용한 개인화된 건강 평가와 가계 서비스에 대한 관심이 높아지면서 소비자 행동도 시장 성장에 영향을 미치고 있습니다. 게다가 COVID-19 팬데믹은 바이러스 돌연변이의 확인과 추적에 있어서 신속한 시퀀싱 기술의 중요성을 부각시키고, 세계의 건강 과제에 대응하는데 있어서 DNA 시퀀싱의 중요한 역할을 부각시켰습니다. 이러한 요인은 DNA 시퀀싱 시장의 지속적인 확대와 혁신에 박차를 가하고 유전체 연구에서 가장 역동적인 분야 중 하나가 되고 있습니다.

조사 대상 기업 예(전 76건)

  • Eppendorf AG
  • Adaptive Biotechnologies Corporation
  • Cofactor Genomics, Inc.
  • Annoroad Gene Technology
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • DayTwo
  • Dynasty Gene
  • Clevergene
  • Ares Genetics GmbH
  • DDL Diagnostic Laboratory
  • DelphiTest GmbH
  • DNA link
  • ARL Bio Pharma, Inc.
  • Celgene Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

BJH

Global DNA Sequencing Market to Reach US$17.1 Billion by 2030

The global market for DNA Sequencing estimated at US$7.8 Billion in the year 2023, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the DNA Sequencing Instruments segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 15.9% CAGR

The DNA Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global DNA Sequencing Market - Key Trends & Drivers Summarized

What Is DNA Sequencing and Why Is It Transformative?

DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The ability to sequence DNA quickly and affordably has become a pivotal factor in biological research, enabling scientists to observe the genetic blueprint that guides the development, functioning, and reproduction of living organisms and viruses. Over the past few decades, advancements in DNA sequencing technologies have revolutionized the field of genomics, leading to profound insights into the genetic bases of many diseases, the evolution of species, and identification of genetic variability among populations.

How Has Technology Advanced in DNA Sequencing?

Technological advancements in DNA sequencing have largely followed the trajectory from first-generation sequencing, which includes methods like Sanger sequencing, to next-generation sequencing (NGS), which allows for sequencing of millions of small fragments of DNA in parallel, significantly reducing the time and cost associated with DNA sequencing. NGS platforms have undergone rapid enhancements that have increased accuracy, speed, and affordability, making large-scale projects like whole-genome sequencing and personalized genomics feasible for more researchers and clinicians. Additionally, the development of third-generation sequencing technologies, which include single-molecule real-time sequencing techniques, promises to further revolutionize the field by offering even faster and more accurate sequencing capabilities without the need for amplification of DNA samples.

What Are the Major Applications of DNA Sequencing?

The applications of DNA sequencing are extensive and varied across multiple fields. In healthcare, it is used for diagnosing genetic disorders, identifying mutations that may lead to cancer, and guiding treatment decisions based on an individual’s genetic makeup. In agriculture, DNA sequencing assists in creating high-yield, pest-resistant crops by enabling precise alterations to the genetic structure of plants. Furthermore, in forensic science, sequencing can identify individuals with high accuracy from minute samples of DNA. Environmental scientists use DNA sequencing to study biodiversity, understand population genetics, and track the effects of environmental changes on genetic material in ecosystems. Each application demonstrates the significant impact of DNA sequencing technologies in advancing our understanding and management of complex biological systems.

Growth in the DNA Sequencing Market Is Driven by Several Factors

The growth in the DNA sequencing market is driven by several factors, including rapid technological advancements, decreasing costs, and expanding applications across various fields. The increasing adoption of precision medicine, which relies heavily on genetic information to tailor individual treatment plans, is a major growth driver. Furthermore, the global rise in genetic research activities, bolstered by government and private funding, contributes significantly to the demand for advanced sequencing solutions. Consumer behavior also influences market growth, as there is a growing interest in personalized health assessments and ancestry services, which utilize DNA sequencing. Additionally, the COVID-19 pandemic highlighted the importance of rapid sequencing technologies in identifying and tracking virus mutations, underscoring the critical role of DNA sequencing in responding to global health challenges. These factors collectively fuel the ongoing expansion and innovation within the DNA sequencing market, making it one of the most dynamic areas in genomics research.

Select Competitors (Total 76 Featured) -

  • Eppendorf AG
  • Adaptive Biotechnologies Corporation
  • Cofactor Genomics, Inc.
  • Annoroad Gene Technology
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • DayTwo
  • Dynasty Gene
  • Clevergene
  • Ares Genetics GmbH
  • DDL Diagnostic Laboratory
  • DelphiTest GmbH
  • DNA link
  • ARL Bio Pharma, Inc.
  • Celgene Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • DNA Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • An Introduction
    • A Brief History on Evolution of DNA Sequencing Technology
    • Different Types of Sequencing Approaches
    • Shotgun Sequencing
    • High-Throughput Approach
    • Long-Read Sequencing Approaches
    • Single Molecule Real Time (SMRT) Sequencing
    • Nanopore DNA Sequencing
    • Short-Read Sequencing Approaches
    • Massively Parallel Signature Sequencing (MPSS)
    • Massively Parallel Signature Sequencing (MPSS)
    • Polony Sequencing
    • 454 Pyrosequencing
    • Illumina (Solexa) Sequencing
    • Combinatorial Probe Anchor Synthesis (cPAS)
    • SOLiD sequencing
    • Ion Torrent Semiconductor Sequencing
    • DNA Nanoball Sequencing
    • Heliscope Single Molecule Sequencing
    • Microfluidic Systems
    • A Prelude to DNA Sequencing
    • Major Applications
    • DNA Sequencing Application
    • Global Market Prospects and Outlook
    • DNA Sequencing Market Set for a Rapid Growth
    • Regional Market Perspective
    • North America Leads the Global Market
    • Competition
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Next Generation Sequencing Drives the Market Growth
    • Increasing R&D Activities in NGS
    • Illumina, the Dominant Force in the Global NGS Market
    • Growing Adoption of Sequencing Services in Clinical Workflows Propels Market Growth
    • Increasing Use in Drug Discovery Drives Market Growth
    • Increasing Emphasis on Personalized Medicine Drives Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Rising Incidence of Cancer to Drive Market Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • DNA Sequencing and Cancer Care
    • Technological Advancements in NGFS Aids Market Expansion
    • The First Mobile Genome Sequence Analyzer in the World
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinical Investigation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Forensics & Agrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for HLA Typing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 39: World 16-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 42: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 45: World 16-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 48: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 49: World DNA Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: USA 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: China Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: China 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: France Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: France 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: UK 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: UK 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • DNA Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of World 16-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제